Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$107.74 USD

107.74
1,970,294

+5.16 (5.03%)

Updated Aug 14, 2024 09:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 21% (197 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research

Investors grew bullish on Nevro's (NVRO) prospects, courtesy of the stock's solid prospects.

Veeva (VEEV) Vault Applications Get Adopted by GenesisCare

by Zacks Equity Research

Veeva Systems' (VEEV) clinical capabilities will allow GenesisCare Clinical CRO to rationalize trial procedures and expedite execution of the same.

Cardinal (CAH) Up 7.4% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is Cardinal Health (CAH) a Good Value Investor Choice Now?

by Zacks Equity Research

Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.

Here's Why You Should Invest in Cardinal Health (CAH) Stock

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Why You Should Retain Pacific Biosciences (PACB) Stock Now

by Zacks Equity Research

Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects.

BD (BDX) to Boost Pre-Fillable Syringe-Manufacturing Capacity

by Zacks Equity Research

BD (BDX) is set to improve its pre-fillable syringe-manufacturing ability with its expansion and upgrade plans.

AMN Healthcare (AMN) Boosts Service Portfolio With New Offering

by Zacks Equity Research

AMN Healthcare's (AMN) new pledge to provide support minority-owned businesses, thereby helping them to thrive.

Why You Should Add Merit Medical (MMSI) to Your Portfolio

by Zacks Equity Research

Investor confidence is high on Merit Medical (MMSI) stock, courtesy of its solid prospects.

    Medtronic (MDT) Shows Strong Sales Recovery Amid COVID-19 Crisis

    by Zacks Equity Research

    Based on the ongoing strong recovery in sales, Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.

    Baxter (BAX) Gets FDA Nod for Homechoice Claria APD System

    by Zacks Equity Research

    Baxter's (BAX) Homechoice Claria combines a simple user interface with the benefits of Sharesource.

    CAH vs. ALGN: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    CAH vs. ALGN: Which Stock Is the Better Value Option?

    Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

    by Zacks Equity Research

    Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

    Nitish Marwah headshot

    Top Ranked Momentum Stocks to Buy for November 25th

    by Nitish Marwah

    Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 25th.

    Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (CAH) Outperforming Other Medical Stocks This Year?

    Here's Why You Should Invest in Cooper Companies (COO) Stock

    by Zacks Equity Research

    Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

    Ecolab (ECL) Gets EPA Nod for Biofilm Disinfectant Virasept

    by Zacks Equity Research

    Ecolab's (ECL) Virasept has been developed to combat bacterial growth in hospitals.

    Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

    by Zacks Equity Research

    Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

      Here's Why You Should Avoid Betting on Integer Holdings (ITGR)

      by Zacks Equity Research

      Stiff competition in the MedTech space and weak segmental and operational third-quarter 2020 performance weighs on Integer Holdings (ITGR).

      Top Ranked Momentum Stocks to Buy for November 20th

      by Zacks Equity Research

      Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 20th.

      NextGen (NXGN) Strengthens Portfolio of NextGen Solutions

      by Zacks Equity Research

      NextGen (NXGN) continues to boost its robust portfolio of NextGen solutions with the latest adoption of NextGen Enterprise by OSMC.

      Sanghamitra Saha headshot

      Rising P/E: An Ignored Trick to Pick 5 Winning Stocks

      by Sanghamitra Saha

      Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

      Veeva Systems (VEEV) Boosts Portfolio of Cloud-Based Offerings

      by Zacks Equity Research

      Veeva Systems (VEEV) continues to boost its cloud-based offerings profile with the adoption of Vault PromoMats by Bristol Myers.

      Here's Why You Should Invest in Cardinal Health (CAH) Stock

      by Zacks Equity Research

      Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

      LHC Group (LHCG) Forays into Oklahoma With New Hospice Buyout

      by Zacks Equity Research

      LHC Group (LHCG) buys Grace Hospice of Oklahoma to expand its hospice service to Tulsa and throughout the nation.